天康生物最新股东户数环比下降9.64%

Group 1 - The core point of the article is that TianKang Biological has seen a significant decrease in the number of shareholders, with a reduction of 6,689 accounts, representing a 9.64% decline compared to the previous period [2] - As of September 23, the latest margin trading balance for the stock is 292 million yuan, with a financing balance of 290 million yuan, indicating a total decrease of 98.82 million yuan, or 25.40%, since the concentration of shares began [2] - The company reported a revenue of 8.847 billion yuan for the first half of the year, reflecting a year-on-year growth of 10.68%, and a net profit of 338 million yuan, which is a 22.27% increase year-on-year [2]